Share Issue News

Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.

Dec 4, 2025 at 9:27 PM

SoFi Technologies, Inc. Announces Pricing of Public Offering of Common Stock

SAN FRANCISCO--(BUSINESS WIRE)--SoFi Technologies, Inc. (NASDAQ: SOFI) (“SoFi” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 54,545,454 shares of its common stock at a price of $27.50 per share, for total gross proceeds of approximately $1.5 billion, before deducting underwriting discounts and commissions and offering expenses payable by the Company. In addition, SoFi has granted the underwriters a 30-day option to purchase up to a...
Dec 4, 2025 at 6:00 PM

Western Metallica Announces Debt Settlement

TORONTO--(BUSINESS WIRE)--Western Metallica Resources Corp. (TSXV: WMS) (“Western Metallica” or the “Company”) announces that it has settled its debt with Gestión de Consensos Socioambientales S.A.C. in the amount of USD $13,648.47 through the issuance of an aggregate of 180,000 common shares of Western Metallica (the "Common Shares") at a deemed price of $0.065 per Common Share and a cash payment of USD $6,000.00. The Common Shares are subject to a statutory hold period until April 5, 2026. Cl...
Dec 4, 2025 at 4:59 PM

SoFi Technologies, Inc. Announces Public Offering of Common Stock

SAN FRANCISCO--(BUSINESS WIRE)--SoFi Technologies, Inc. (NASDAQ: SOFI) (“SoFi” or the “Company”) today announced an underwritten public offering of $1.5 billion of shares of its common stock. In connection with the offering, SoFi expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering. All of the shares of common stock in the offering will be sold by SoFi. SoFi intends to use the net proceeds from the offering fo...
Dec 4, 2025 at 4:15 PM

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fix...
Dec 4, 2025 at 4:05 PM

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 1, 2025, the Compensation Committee of the company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 88,000 shares of common stock to four new employees under the Company’s 2024 Indu...
Dec 4, 2025 at 5:58 AM

Groupe SEB: Monthly Disclosure of the Total Number of Shares and Voting Rights – 30.11.2025

ECULLY, France--(BUSINESS WIRE)--Regulatory News: Issuer Corporate name: SEB S.A. (Paris:SK) Registered office: 112 Chemin du Moulin Carron, 69130 Ecully- France Stockmarket: Euronext Paris - A ISIN: FR0000121709 Numbers of shares and voting rights :   31 October 2025 30 November 2025 Shares in Euronext (1) 55 337 770 55 337 770 Theoretical voting rights (2) 80 099 095 80 014 404 Effective voting rights 79 542 391 79 459 608 (1) Shares with a par value of 1€ (2) Including voting rights attached...
Dec 3, 2025 at 5:29 PM

BKV Corporation Announces Closing of Public Offering of Common Stock

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced the closing of its underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $26.00 per share, which amount includes 900,000 shares issued pursuant to the underwriters’ exercise of their option to purchase additional shares. BKV received net proceeds from this offering of approximately $170.3 million after deducting underwriters’ discounts and commissions and estimated offering...
Dec 3, 2025 at 4:05 PM

Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that on December 2, 2025, the Compensation and Management Development Committee of Alto’s Board of Directors granted a new employee an option to purchase 150,000 shares of Alto’s common stock. The stock option was granted under Alto’s 2025 Inducement Plan as a mate...
Dec 3, 2025 at 12:00 PM

Legrand: Total Number of Shares and Voting Rights

LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR): Date Total number of shares composing the share capital Total number of voting rights November 30, 2025 262,245,733 Theoretical number of voting rights: 262,245,733 Number of exercisable voting rights*: 261,867,240 (*) After deduction of shares without voting rights The variation of the total number of shares since the latest release of financial statements is reminded below: Total number of shares as at September 30, 2025 2...
Dec 3, 2025 at 11:45 AM

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 36,741,587 Number of real voting rights* (excluding treasury shares**) 36,669,667 Theoretical number of voting rights* (including treasury shares**) 36,718,387 (*) Class E preference shares are non-voting (**) pursuant to article 223-11 of the AMF’s General Regulations About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Tech...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up